• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注入癌症患者体内的淋巴因子激活的杀伤细胞被烟曲霉污染。

Aspergillus fumigatus contamination of lymphokine-activated killer cells infused into cancer patients.

作者信息

Arnow P M, Houchins S G, Richards J M, Chudy R

机构信息

Department of Medicine, University of Chicago Hospitals, Illinois 60637.

出版信息

J Clin Microbiol. 1991 May;29(5):1038-41. doi: 10.1128/jcm.29.5.1038-1041.1991.

DOI:10.1128/jcm.29.5.1038-1041.1991
PMID:2056038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC269930/
Abstract

Lymphokine-activated killer (LAK) cells, prepared by incubating autologous lymphocytes in cell culture medium with interleukin-2, selectively lyse tumor cells and are effective immunotherapy of some cancers. During a 3-month period, two patients at our center were infused with LAK cells subsequently found to have been contaminated by Aspergillus fumigatus. Each case was investigated by obtaining environmental cultures and assessing aseptic practices during LAK cell preparation. Investigation of the first case demonstrated a malfunction of the laminar air flow hood, under which interleukin-2 and the patient's lymphocytes had been added to cell culture medium, and showed heavy A. fumigatus contamination of the hood, adjacent countertop, and cell culture incubator. Despite repair of the laminar air flow hood and cleaning of the laboratory, a second case occurred, and cultures at that time implicated the humidified cell culture incubators as the source of A. fumigatus. Following incubator sterilization and removal of the humidification apparatus from the incubators, weekly environmental cultures in the LAK cell laboratory were negative, and none of the LAK cell cultures from the 20 patients treated during the ensuing 15 months grew A. fumigatus. Our findings show that growth of fungi in humidified incubators, which previously has caused contamination problems in tissue culture and clinical microbiology laboratories, can result in patient infections when humidified incubators are used to prepare cells for reinfusion.

摘要

通过在细胞培养基中用白细胞介素-2孵育自体淋巴细胞制备的淋巴因子激活的杀伤(LAK)细胞可选择性地裂解肿瘤细胞,是某些癌症的有效免疫疗法。在3个月的时间里,我们中心的两名患者输注了后来被烟曲霉污染的LAK细胞。通过获取环境培养物并评估LAK细胞制备过程中的无菌操作对每个病例进行了调查。对第一个病例的调查表明,在将白细胞介素-2和患者的淋巴细胞添加到细胞培养基的层流通风橱出现故障,通风橱、相邻的台面和细胞培养箱均被烟曲霉严重污染。尽管对层流通风橱进行了维修并对实验室进行了清洁,但仍发生了第二例病例,当时的培养物表明加湿的细胞培养箱是烟曲霉的来源。在对培养箱进行灭菌并从培养箱中移除加湿装置后,LAK细胞实验室的每周环境培养均为阴性,在随后的15个月中接受治疗的20名患者的LAK细胞培养物均未生长出烟曲霉。我们的研究结果表明,加湿培养箱中真菌的生长,此前已在组织培养和临床微生物学实验室中引起污染问题,当使用加湿培养箱制备用于回输的细胞时,可能导致患者感染。

相似文献

1
Aspergillus fumigatus contamination of lymphokine-activated killer cells infused into cancer patients.注入癌症患者体内的淋巴因子激活的杀伤细胞被烟曲霉污染。
J Clin Microbiol. 1991 May;29(5):1038-41. doi: 10.1128/jcm.29.5.1038-1041.1991.
2
Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms.与曲霉菌在医院内繁殖相关的地方性和流行性曲霉菌病。
J Infect Dis. 1991 Nov;164(5):998-1002. doi: 10.1093/infdis/164.5.998.
3
Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.黑色素瘤或肾细胞癌患者产生黏附性淋巴因子激活杀伤细胞的能力降低。
J Immunother (1991). 1991 Oct;10(5):336-46. doi: 10.1097/00002371-199110000-00005.
4
Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resection.采用淋巴因子激活的T杀伤细胞联合姑息性肿瘤切除进行过继性免疫治疗后犬外周血淋巴细胞计数的变化
Vet Immunol Immunopathol. 2016 Sep;177:58-63. doi: 10.1016/j.vetimm.2016.06.007. Epub 2016 Jun 16.
5
Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.短暂暴露于粒细胞-巨噬细胞集落刺激因子后增强的人淋巴因子激活的杀伤细胞功能。
Cancer. 1995 Oct 1;76(7):1253-60. doi: 10.1002/1097-0142(19951001)76:7<1253::aid-cncr2820760724>3.0.co;2-f.
6
Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.白细胞介素15通过一种依赖CD18且与穿孔素相关的机制诱导黑色素瘤患者淋巴细胞中淋巴因子激活的杀伤细胞对自体肿瘤细胞的功能。
Cancer Res. 1995 Nov 1;55(21):4988-94.
7
Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignancies.人类白细胞抗原不匹配的同种异体淋巴因子激活的杀伤细胞和白细胞介素-2在恶性肿瘤患者过继性免疫治疗中的应用。
Hum Cell. 1992 Sep;5(3):226-35.
8
Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats.两只老龄猫抗癌治疗后进行淋巴因子激活的杀伤细胞移植
Open Vet J. 2019 Jul;9(2):147-150. doi: 10.4314/ovj.v9i2.9. Epub 2019 May 13.
9
A high density cell culture system for generation of human lymphokine-activated killer (LAK) cells for clinical use in adoptive immunotherapy.一种用于生成人淋巴因子激活的杀伤(LAK)细胞的高密度细胞培养系统,用于过继性免疫治疗的临床应用。
J Clin Lab Immunol. 1990 May;32(1):41-7.
10
Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes.外源性白细胞介素2通过体内活化的淋巴细胞募集体外淋巴因子激活的杀伤活性。
Cancer Res. 1991 May 1;51(9):2324-8.

引用本文的文献

1
Overview of a quality assurance/quality control compliance program consistent with FDA regulations and policies for somatic cell and gene therapies: a four year experience.符合美国食品药品监督管理局(FDA)关于体细胞和基因治疗法规及政策的质量保证/质量控制合规计划概述:四年经验
Cytotechnology. 1994;15(1-3):365-72. doi: 10.1007/BF00762411.

本文引用的文献

1
Fungi in fluids--a hazard of intravenous therapy.液体中的真菌——静脉治疗的一种风险。
J Med Microbiol. 1970 Feb;3(1):99-102. doi: 10.1099/00222615-3-1-99.
2
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.关于使用淋巴因子激活的杀伤细胞和白细胞介素-2或单独使用高剂量白细胞介素-2治疗157例晚期癌症患者的进展报告。
N Engl J Med. 1987 Apr 9;316(15):889-97. doi: 10.1056/NEJM198704093161501.
3
NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.美国国立卫生研究院会议。使用白细胞介素-2进行癌症免疫治疗的新方法。
Ann Intern Med. 1988 Jun;108(6):853-64. doi: 10.7326/0003-4819-108-6-853.
4
A new regimen of interleukin 2 and lymphokine-activated killer cells. Efficacy without significant toxicity.白细胞介素2与淋巴因子激活的杀伤细胞的新治疗方案。疗效显著且毒性不大。
Arch Intern Med. 1988 Dec;148(12):2571-6.
5
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.采用白细胞介素-2和淋巴因子激活的杀伤细胞治疗转移性肾癌。一项II期临床试验。
Ann Intern Med. 1988 Apr;108(4):518-23. doi: 10.7326/0003-4819-108-4-518.
6
Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model.免疫抑制和两性霉素B对实验模型中曲霉抗原血症的影响。
J Infect Dis. 1988 Aug;158(2):415-22. doi: 10.1093/infdis/158.2.415.
7
Some observations on contamination of animal cell cultures by the fungus Aspergillus fumigatus and suggested control measures.关于烟曲霉对动物细胞培养物污染的一些观察及建议的控制措施。
Cell Biol Int Rep. 1989 Sep;13(9):773-9. doi: 10.1016/0309-1651(89)90054-4.
8
Antigenemia in a rabbit model of invasive aspergillosis.侵袭性曲霉病兔模型中的抗原血症
J Infect Dis. 1989 Jun;159(6):1147-50. doi: 10.1093/infdis/159.6.1147.
9
An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells.在接受白细胞介素-2和淋巴因子激活的杀伤细胞治疗的癌症患者中爆发甲型肝炎。
J Infect Dis. 1990 Apr;161(4):647-52. doi: 10.1093/infdis/161.4.647.
10
An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy.接受白细胞介素-2免疫治疗的患者中性粒细胞存在获得性趋化缺陷。
N Engl J Med. 1990 Apr 5;322(14):959-65. doi: 10.1056/NEJM199004053221404.